If a medical card patient was receiving their medicines as phased dispensing or in a blister pack free-of-charge in August 2025 they can continue to receive their medicines in this way. They will not be charged for this service.
Under the GMS medicines optimisation support service, vulnerable GMS patient groups including those with diagnosed cognitive impairment or dementia, intellectual disability, physical impairment or those patients at risk of medication misuse will be supported where appropriate with a range of tailored supports including:
• adjustments to facilitate use of original packaging.
• medication reminder systems.
• administration charts.
• installment dispensing; and
• blister packs where clinically necessary.
Blister packs will remain a last resort in line with the international evidence due to associated risks including reduced patient autonomy and potential safety concerns. Where clinically required, and deemed appropriate, blister packs will be provided free-of-charge to eligible medical card patients, in identified cohorts.